发明申请
- 专利标题： PIPERIDINE DERIVATIVES FOR GPR119 AGONIST
- 专利标题（中）： GPR119激动剂的哌啶衍生物
-
申请号： US14407214申请日： 2013-06-11
-
公开(公告)号： US20150166480A1公开(公告)日： 2015-06-18
- 发明人: ChangSik Lee , TaegSu Jang , DaeKyu Choi , MooSung Ko , DoHoon Kim , SoYoung Kim , JaeKi Min , WooSik Kim , YoungTae Lim
- 申请人： CHONG KUN DANG PHARMACEUTICAL CORP.
- 申请人地址： KR Seoul
- 专利权人： CHONG KUN DANG PHARMACEUTICAL CORP.
- 当前专利权人： CHONG KUN DANG PHARMACEUTICAL CORP.
- 当前专利权人地址： KR Seoul
- 优先权： KR10-2012-0062784 20120612
- 国际申请： PCT/KR2013/005096 WO 20130611
- 主分类号： C07D211/22
- IPC分类号： C07D211/22 ; C07D401/14 ; C07D405/12 ; C07D401/12 ; C07D409/12
摘要：
The present invention relates to novel piperidine derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel piperidine derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.
公开/授权文献
- US09944600B2 Piperidine derivatives for GPR119 agonist 公开/授权日：2018-04-17
信息查询
